Indication

Chronic hepatitis C - genotype 4

Chronic hepatitis C – genotype 4 is a persistent hepatic infection lasting longer than six months caused by genotype 4 of the hepatitis C virus (HCV), an enveloped positive-sense single-stranded RNA virus. Read more about Chronic hepatitis C - genotype 4

31 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis C - genotype 4 therapies.

Showing 1–9 of 31 drugs

RIBAVIRIN

RIBAVIRIN·CHRONIC HEPATITIS C - GENOTYPE 1·+3
AUROBINDO PHARM

RIBAVIRIN

RIBAVIRIN·CHRONIC HEPATITIS C - GENOTYPE 1·+3
ZYDUS PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis C - genotype 4 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis C - genotype 4.

Chronic hepatitis C – genotype 4 is a persistent hepatic infection lasting longer than six months caused by genotype 4 of the hepatitis C virus (HCV), an enveloped positive-sense single-stranded RNA virus.

Predominantly affecting the liver across adult and pediatric populations—historically most prevalent in North Africa and the Middle East—this viral subtype induces chronic necroinflammation of hepatocytes and immune-mediated tissue injury.

While the infection is often clinically silent for years, ongoing viral persistence promotes progressive hepatic fibrosis, which can advance to cirrhosis, end-stage liver disease, portal hypertension, and hepatocellular carcinoma.

The genotype 4 classification specifically denotes a distinct viral genomic lineage defined by molecular diagnostics, which has historically informed antiviral drug responsiveness and regimen selection.

Personalize your experience

Follow Chronic hepatitis C - genotype 4 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it